|
Today's Headlines
Congress passed the 2011 Generating Antibiotics Incentives Now (GAIN) Act to help boost development in the field, but it appears that these incentives have done little to promote novel antibiotic development.
» Explore the pipeline
|
|
Nonvalvular atrial fibrillation (NVAF) patients taking uninterrupted rivaroxaban or warfarin had a low rate of major bleeding and thromboembolic complications, according to datapresented at Heart Rhythm 2015, the Heart Rhythm Society's 36th Annual Scientific Sessions, and published in the European Heart Journal.
» Study details
|
Continuing Education
This month's CE activity is part of the CE series, MTM for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.
The goal of this month's activity is to review the stepwise approach to the management of pediatric and adult asthma and the pharmacotherapies commonly used in asthma treatment.
To read and print the article with TEST questions, click here
To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT30-PYJ23.
Announcement: The login to the Online CE Center is
https://web2.uconn.edu/pharmacyce/login.php. All current user registration has been uploaded for your convenience. Current users do not need to register. To review you registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/
|
|
EDITOR'S PICK
Oral therapies are revolutionizing the treatment paradigm of multiple sclerosis (MS) by offering enhanced dosing and patient compliance, according to new analysis. » Analysis details
|
|
|
Like
Tweet
